Binosto FDA Approval History
FDA Approved: Yes (First approved March 12, 2012)
Brand name: Binosto
Generic name: alendronate
Dosage form: Effervescent Tablets
Company: EffRx Pharmaceuticals SA
Treatment for: Osteoporosis
Binosto (alendronate) is a buffered effervescent dosage form of the bisphosphonate drug alendronate sodium administered once weekly for the treatment of osteoporosis.
Development Timeline for Binosto
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.